A woman from Madison is fulfilling her dream of opening a bookstore with her daughter after recovering from breast cancer.

Updated data from the Phase III TALAPRO-2 trial show that the combination of Talzenna (talazoparib) and Xtandi (enzalutamide) significantly improves overall survival in patients with metastatic ...

Pfizer (PFE) announced results from the Phase 3 TALAPRO-2 study of TALZENNA, an oral poly ADP-ribose polymerase inhibitor, in combination with ...

Pfizer Inc. (NYSE: PFE) today announced positive results from the Phase 3 TALAPRO-2 study of TALZENNA® (talazoparib), an oral ...

Pfizer hopes a unique life-extension benefit for its Talzenna can serve to further expand the drug’s already ...

Researchers determined the clinical classification of more than 90% of potential BRCA2 variants of uncertain significance in ...

Cancer has been regarded traditionally as a disease of aging. Routine screening for cancer is advised for individuals aged 40 ...

A Queensland oncologist has warned of the deadly link between family inherited breast cancer and ovarian cancer and the need ...

An Arkansas mom of three is sharing her story of overcoming breast cancer, and how an unexpected genetic twist led to some ...

Caris Life Sciences® (Caris), a leading next-generation AI TechBio company and precision medicine pioneer, today announced ...

AstraZeneca announced that its drug Lynparza (olaparib) has been approved for use in Scotland. The approval by the Scottish ...